CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 95 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,434,457 | -7.3% | 81,858 | -43.8% | 0.00% | 0.0% |
| Q2 2023 | $2,625,387 | +176.3% | 145,693 | +146.2% | 0.00% | – |
| Q1 2023 | $950,238 | -35.7% | 59,168 | -26.7% | 0.00% | -100.0% |
| Q4 2022 | $1,476,700 | +822.9% | 80,694 | +891.4% | 0.00% | – |
| Q3 2022 | $160,000 | -55.3% | 8,139 | -57.6% | 0.00% | – |
| Q2 2022 | $358,000 | -76.2% | 19,180 | -72.0% | 0.00% | -100.0% |
| Q1 2022 | $1,504,000 | +0.3% | 68,493 | +29.7% | 0.00% | – |
| Q4 2021 | $1,500,000 | +235.6% | 52,820 | +148.8% | 0.00% | – |
| Q3 2021 | $447,000 | +609.5% | 21,227 | +414.1% | 0.00% | – |
| Q1 2021 | $63,000 | +110.0% | 4,129 | +96.7% | 0.00% | – |
| Q4 2020 | $30,000 | -81.1% | 2,099 | -76.9% | 0.00% | – |
| Q2 2020 | $159,000 | +31.4% | 9,093 | +10.7% | 0.00% | – |
| Q1 2020 | $121,000 | -71.8% | 8,216 | -51.9% | 0.00% | – |
| Q4 2019 | $429,000 | +210.9% | 17,087 | +85.7% | 0.00% | – |
| Q3 2019 | $138,000 | +711.8% | 9,199 | +1242.9% | 0.00% | – |
| Q2 2019 | $17,000 | -98.3% | 685 | -98.4% | 0.00% | – |
| Q1 2019 | $988,000 | +5388.9% | 43,416 | +7196.8% | 0.00% | – |
| Q4 2018 | $18,000 | -61.7% | 595 | -63.7% | 0.00% | – |
| Q3 2018 | $47,000 | – | 1,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,126,579 | $33,504,459 | 14.02% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $4,193,340 | 5.38% |
| First Light Asset Management, LLC | 1,583,329 | $47,088,204 | 4.47% |
| Paradigm Biocapital Advisors LP | 2,178,737 | $64,795,638 | 4.40% |
| Bain Capital Life Sciences Investors, LLC | 1,275,552 | $37,934,916 | 4.24% |
| Altium Capital Management LP | 262,000 | $7,791,880 | 4.06% |
| 5AM Venture Management, LLC | 462,286 | $13,748,386 | 3.96% |
| MPM BioImpact LLC | 479,053 | $14,247,036 | 3.80% |
| Affinity Asset Advisors, LLC | 450,000 | $13,383,000 | 3.76% |
| Opaleye Management Inc. | 370,000 | $11,003,800 | 3.58% |